FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

DCAL

164
-6.1 (-3.59%)
Updated 03:28 18/09 IST

DCAL Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for DCAL
Disclaimer
0% Bullish
0% Bearish

DCAL Buy or Sell - Brokerage Reports

No. of reports in last year
4
No. of analysts
1
Average Consensus Forecast
181.75
Consensus Potential
6.32%
See DCAL Share Price Targets >>

DCAL Ratings

Long term DCAL rating by FrontPage users
5/5 (5 Ratings)
Find answers to all your questions on live DCAL message board: Is DCAL buy or sell? Should I buy DCAL shares? Why are DCAL shares falling? Should I invest in DCAL stock?

  1. Home
  2. DCAL Forum

DCAL Share Price Discussion

R
Reputation: 48 • Sep 14 5:00 AM

Nirmal Bang target on DCAL
Date: 10-Sep-20 Broker: Nirmal Bang Price @ Call: 167.23 Target: 172 Potential: 0.03% Recommendation: ACCUMULATE
Like
Reply
R
Reputation: 48 • Sep 14 5:00 AM

Sharekhan target on HINDUNILVR
Date: 10-Sep-20 Broker: Sharekhan Price @ Call: 2128.93 Target: 2550 Potential: 0.2% Recommendation: BUY
Like
Reply
R
Reputation: 48 • Sep 14 5:00 AM

Sharekhan target on MARUTI
Date: 10-Sep-20 Broker: Sharekhan Price @ Call: 7230.89 Target: 8000 Potential: 0.11% Recommendation: BUY
Like
Reply
R
Reputation: 48 • Sep 14 5:00 AM

Motilal Oswal target on BHEL
Date: 11-Sep-20 Broker: Motilal Oswal Price @ Call: 37.38 Target: 22 Potential: -0.41% Recommendation: SELL
Like
Reply
R
Reputation: 48 • Sep 14 5:00 AM

Motilal Oswal target on CROMPTON
Date: 11-Sep-20 Broker: Motilal Oswal Price @ Call: 253.3 Target: 310 Potential: 0.22% Recommendation: BUY
Like
Reply
K
Reputation: -706 • Sep 14 4:59 AM

Type
Buy
Instrument
BANKNIFTY 17SEP20 23000 CE
Entry Price
₹160
Price@Trade
₹161.5
Target Price
₹171
Stop Price
₹149
Valid Till
Sep 14, 2020 3:20 AM
Margin
₹40,000 approx for 250 Qty
Status
Waiting for entry
Like
Reply
C
Reputation: 7,017 • Sep 14 4:59 AM
Like
Reply
R
Reputation: -15,598 • Sep 14 4:59 AM

Type
Buy
Instrument
TATAMOTORS SEP20 FUT
Entry Price
₹150
Price@Trade
₹150.25
Target Price
₹151
Stop Price
₹149.9
Valid Till
Sep 14, 2020 3:20 AM
Margin
₹767,391 approx for 11400 Qty
Status
Waiting for entry
Like
Reply
K
Reputation: -706 • Sep 14 4:59 AM

Type
Buy
Instrument
BANKNIFTY 17SEP20 23000 CE
Entry Price
₹159
Price@Trade
₹163.85
Target Price
₹170
Stop Price
₹149
Valid Till
Sep 14, 2020 3:20 AM
Margin
₹397,500 approx for 2500 Qty
Status
Waiting for entry
Like
Reply
V
Reputation: -45,127 • Sep 14 4:59 AM

Type
Buy
Instrument
BANKNIFTY 17SEP20 22500 PE
Entry Price
₹212.65
Price@Trade
₹212.65
Target Price
₹600
Stop Price
₹99
Valid Till
Sep 17, 2020 3:20 AM
Margin
₹63,795 approx for 300 Qty
Status
Exited
Exit Price
₹217.7
Net P&L
+₹1,515 (+2.37%)
Like
Reply (1)
See all replies
Vikash @vikash-S1BQsL5zw
Sep 14 5:00 AM

Update
Exited
Exit Price
₹217.7
Net P&L
+₹1,515 (+2.37%)
S
Reputation: 550 • Sep 14 4:58 AM

Type
Sell
Instrument
CRUDEOIL 21SEP20 FUT
Entry Price
₹2,761
Price@Trade
₹2,758
Target Price
₹2,740
Stop Price
₹2,771
Valid Till
Sep 14, 2020 11:20 AM
Margin
₹277,747.5 approx for 100 Qty
Status
Waiting for entry
Like
Reply

Type
Buy
Instrument
TATAMOTORS SEP20 150 CE
Entry Price
₹6.9
Price@Trade
₹6.9
Target Price
₹9
Stop Price
₹6
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹39,330 approx for 5700 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
TITAN SEP20 FUT
Entry Price
₹1,183
Price@Trade
₹1,183.3
Target Price
₹1,188
Stop Price
₹1,180
Valid Till
Sep 14, 2020 3:20 AM
Margin
₹224,051.63 approx for 750 Qty
Status
Waiting for entry
Like
Reply
O
Reputation: 196,572 • Sep 14 4:56 AM
2
Reply (1)
See all replies
Crazy Trade @crazytrade
Sep 14 4:57 AM

😂😂😂😂😂

Investing University - 1304242
In my list of ‘must read books’, *Banker to the Poor* holds a very special place. 📙
This book has altered my way of thinking when it comes to contributing to the poor.
The author of this book, Muhammad Yunus is the first *Nobel Prize winner* from Bangladesh. 🏆
He truly deserv...
Read more...
Like
Reply
V
Reputation: -45,127 • Sep 14 4:56 AM

Type
Buy
Instrument
BANKNIFTY 17SEP20 22500 PE
Entry Price
₹221.35
Price@Trade
₹221.35
Target Price
₹600
Stop Price
₹99
Valid Till
Sep 17, 2020 3:20 AM
Margin
₹66,405 approx for 300 Qty
Status
Exited
Exit Price
₹223.05
Net P&L
+₹510 (+0.77%)
Like
Reply (1)
See all replies
Vikash @vikash-S1BQsL5zw
Sep 14 4:56 AM

Update
Exited
Exit Price
₹223.05
Net P&L
+₹510 (+0.77%)
N
Reputation: 5,864 • Sep 14 4:56 AM
ICICI Lombard inks bancassurance tie up with Yes Bank for selling insurance products
"The partnership will provide the bank's diverse customer base access to the insurer's portfolio and make insurance more accessible to its customers across India," ICICI Lombard General Insurance Company said in a regulatory filing.
The Economic Times
Like
Reply
P
Reputation: 88,053 • Sep 14 4:56 AM

Type
Buy
Instrument
CADILAHC SEP20 370 CE
Entry Price
₹11.7
Price@Trade
₹11.7
Target Price
₹20
Stop Price
₹9
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹51,480 approx for 4400 Qty
Status
Active
Like
Reply
9
Reputation: 3,091 • Sep 14 4:55 AM

Type
Buy
Instrument
BHARTIARTL SEP20 FUT
Entry Price
₹483
Price@Trade
₹483
Target Price
₹500
Stop Price
₹475
Valid Till
Sep 15, 2020 3:20 AM
Margin
₹274,100.89 approx for 1851 Qty
Status
Active
Like
Reply
Y
Reputation: 670 • Sep 14 4:55 AM

Type
Buy
Instrument
TATACHEM SEP20 FUT
Entry Price
₹302.6
Price@Trade
₹302.8
Target Price
₹315
Stop Price
₹298
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹198,364 approx for 2000 Qty
Status
Active
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Sep 14 4:56 AM

Update
Trade Entered
Entry Price
₹302.6
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • DCAL - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization3,379.72
    Enterprise Value3,819.37
    Price to Earnings139.85
    Price to Book Value0.69
    Return on Capital Employed0.01
    Return on Equity0.01
    Face Value2
    Dividend YieldNA
  • DCAL - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    10-Sep-20Nirmal BangAccumulate172
    28-Jan-20Nirmal BangBuy185
    27-Dec-19Nirmal BangBuy185
    25-Oct-19Nirmal BangBuy185
    20-Sep-19HDFC SecuritiesBuy350
    DCAL Brokerage Price Target
  • DCAL Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 18172178.6162.1163.8
    Sep 17175177.75168.75170.1
    Sep 16180.5183.65172.5177.6
    Sep 15174.8177.6167.6177.6
    Sep 14161.1169.15161.1169.15
  • DCAL Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹177.12
    30 Day Moving Average₹182.31
    50 Day Moving Average₹180.69
    100 Day Moving Average₹139.01
    200 Day Moving Average₹112.36
  • DCAL - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue474451.490.05
    Operating Profit166148.130.12
    Profit Before Tax6243.910.41
    Net Income3724.240.53
  • DCAL - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds4,8924,7780.02
    Total Liabilities9241,060-0.13
    Total Assets5,8165,839-0
  • DCAL - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity20270.38-0.93
    Cash from Investing Activity-175-15.7210.13
    Cash from Financing Activity142-225.38-1.63
    Net Cash Flow-1229.28-1.41
  • DCAL - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.01NA
    Return on Equity0.010.01
    Return on Capital Employed0.010.02
  • DCAL - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in RevenueNA
    3 Year CAGR Growth in Operating ProfitNA
    3 Year CAGR Growth in EBIDTANA
    3 Year CAGR Growth in Net Income75
    3 Yr CAGR Growth - Diluted EPS1.11
  • DCAL - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in RevenueNA
    5 Year CAGR Growth in Operating ProfitNA
    5 Year CAGR Growth in EBIDTANA
    5 Year CAGR Growth in Net IncomeNA
    3 Yr CAGR Growth - Diluted EPSNA
  • DCAL - Recent News

    keyboard_arrow_down
    NewsBot
    Jul 28 3:48 AM
    June quarter report: Rakesh Jhunjhunwala raises stake in 8 companies, reduces exposure in 2
    Moneycontrol
    NewsBot
    Jul 21 3:48 AM
    Rakesh, Rekha Jhunjhunwala acquire 3.2% stake in Dishman, Vijay Kedia buys shares in Ramco in Q1 FY21
    Moneycontrol
    NewsBot
    Jun 4 6:53 AM
    Dishman Carboge Standalone March 2020 Net Sales at Rs 151.92 crore, down 21.49% Y-o-Y
    Moneycontrol
    NewsBot
    Feb 7 3:48 AM
    MFs raise stake in over 200 BSE500 firms, 17 Sensex stocks in Q3; should you buy?
    Moneycontrol
    NewsBot
    Jan 24 7:33 AM
    Dishman Carboge Standalone December 2019 Net Sales at Rs 117.68 crore, down 3.03% Y-o-Y
    Moneycontrol
    NewsBot
    Oct 3, 2019 2:08 AM
    Stocks in the news: Yes Bank, Hero MotoCorp, GMR Infra, Eicher Motors, Tata Motors, M&M, NMDC
    Moneycontrol
    NewsBot
    Aug 21, 2019 3:29 AM
    Buy Dishman Carbogen Amcis; target of Rs 355: HDFC Securities
    Moneycontrol
    NewsBot
    Aug 13, 2019 11:13 AM
    Dishman Carboge Standalone June 2019 Net Sales at Rs 133.41 crore, up 8.65% Y-o-Y
    moneycontrol.com
    NewsBot
    Aug 2, 2019 2:08 AM
    Stocks in the news: Bharti Airtel, SBI, ITC, Eicher Motors, Raymond, Tata Power, Tata Motors
    moneycontrol.com
    NewsBot
    May 15, 2019 9:38 AM
  • DCAL - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020